New Nanoparticle Created by UT Arlington Physicist for Cancer Therapy

A luminescent nanoparticle is being created by a physicist from University of Texas at Arlington, to use in security-related radiation detection, could be an advance in photodynamic cancer therapy.

Wei Chen, professor of physics and co-director of UT Arlington's Center for Security Advances Via Applied Nanotechnology, was testing a copper-cysteamine complex created in his lab when he discovered unexplained decreases in its luminescence, or light emitting power, over a time-lapse exposure to X-rays. Looking further, he found that the nanoparticles, called Cu-Cy, were losing energy as they emitted singlet oxygen - a toxic byproduct that is used to damage cancer cells in photodynamic therapy. Because Chen also is leading federally funded cancer research, he knew he had found something unique.

Chemotherapy Reduces Deaths in Early Breast Cancer

Chemotherapy used in early breast cancer as adjuvant treatment reduces deaths due to breast cancer by one third. The newer chemotherapy regimens appear to be more effective in this regard.

Testing revealed that the Cu-Cy nanoparticles, combined with X-ray exposure, significantly slowed tumor growth in lab studies. "This new idea is simpler and better than previous photodynamic therapy methods. You don't need as many steps. This material alone can do the job," Chen said. "It is the most promising thing we have found in these cancer studies and we've been looking at this for a long time." Chen's research is being published in the August edition of the Journal of Biomedical Nanotechnology under the title "A New X-Ray Activated Nanoparticle Photosensitizer for Cancer Treatment." Co-authors are Lun Ma, a research assistant professor, and Xiaoju Zou, a research associate.

The paper is available online at www.aspbs.com. The University has also filed a provisional patent application on the new complex. Photodynamic therapy, or PDT, harms cancer cells when a photosensitizer introduced into tumor tissue produces toxic

Microarray Technology May Be the Game Changer in Diagnosis of Leukemia

Microarray technology that can search millions of chromosomes quickly allows better diagnosis of previously undetected cases of acute myelogenous leukemia.

singlet oxygen after being exposed to light. In some studies, this light exposure is done through use of visible or near-infrared lasers. Others have found more success by also introducing luminescent nanoparticles into the tumor. Researchers activate the luminescent nanoparticle with near-infrared light or X-rays, which in turn activates the photosensitizer. Source: Eurekalert